Molecular Data EBIT

Molecular Data (MKD) currently reports a EBIT of $-190M as of December 2020. That is below the Industrials sector average of $41B. Use the charts on this page to explore Molecular Data's EBIT history and peer comparisons.

Molecular Data's EBIT of $-190M is lower than the Industrials sector average of $41B. That is roughly 100.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Molecular Data reported $-190M in EBIT as of December 2020. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-190M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is $41B. From there, open related valuation or income-statement pages for Molecular Data, and consider following MKD for alerts when major investors trade the stock.

Molecular Data is classified in the Industrials sector. On EBIT, it currently shows $-190M versus a sector average near $41B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing MKD with unrelated industries.